Accelerate your R&D and conserve precious clinical material with simultaneous detection of multiple targets.
Based on Akoya technology, our mIF services provide unparalleled speed and performance, enabling spatial signatures at scale. Our mIF experts have developed an industry leading GCLP compliant workflow for assay establishment and validation of custom mIF assays and associated digital image analysis algorithms. Assay development considers not only single-plex DAB stain as ground truth, but stripping efficiency, epitope sensitivity and optimal target-fluorophore pairing.
For examples of Discovery’s approach to novel mIF assays please see our resources below
See how Discovery’s experts used mIF assays and digital image analysis to investigate tumor budding in clinical colorectal cancer specimens by evaluating the tumor microenvironment, activated fibroblasts and MSI/MMRD status.
See a demonstration of Discovery’s highly standardized approach to novel mIF assay implementation to support clinical trials.
Join Discovery Life Sciences at Phacilitate's Advanced Therapies Week 2025, Jan 20-23 in Dallas! Visit us at Booth 161 and join Dr. Yuki Maves' presentation on Jan 23. Supply Chain: […]
Join Discovery at Precision Medicine Tri-Con 2025.
Join Discovery at World CB & CDx Summit Europe 2025.
Copyright © 2024 Discovery Life Sciences. All rights reserved.
Designed & Developed by Altitude Marketing
